Document 1011 DOCN M9541011 TI Endemic transmission of HTLV type II among Kayapo Indians of Brazil. DT 9504 AU Black FL; Biggar RJ; Neel JV; Maloney EM; Waters DJ; Department of Epidemiology and Public Health, Yale University; School of Medicine, New Haven, Connecticut 06520-8034. SO AIDS Res Hum Retroviruses. 1994 Sep;10(9):1165-71. Unique Identifier : AIDSLINE MED/95127299 AB Serological studies on 926 blood samples from 703 Brazilian Kayapo (Cayapo) Indians showed, by conventional definition of HTLV seropositivity, a 28% prevalence of human T lymphotropic virus (HTLV) infection, the highest yet reported. Immunoblot (WB) and SYNTH-EIA patterns indicate that the predominant infecting agent is type II. Of children under 15 years old, 12% were positive, and of persons over 60, more than 60%. Perinatal and heterosexual modes of transmission offer an adequate explanation of this incidence. Infection in infancy may include infection via breast milk from women other than the mother. Evidence of new infection in adults is apparent at an earlier age in women than in men. This pattern of antibody prevalence was not determined by cohort effects, as demonstrated by tests of serial specimens. Enzyme immunosorbent assay (EIA) absorbencies were not stable in the paired specimens: five serum pairs reverted and mean absorbencies declined over some age ranges. Many specimens with relatively high, but less than positive, EIA results were positive by immunoblot (WB). This suggests that the standard EIA end point does not identify all infected persons. If the WB alone indicates positivity, 47% of the whole population, and more than 80% of the older age groups, are infected with HTLV-II. DE Adolescence Adult Age Factors Brazil/EPIDEMIOLOGY Child Child, Preschool Comparative Study Demography Enzyme-Linked Immunosorbent Assay Family Female Human HTLV-II Antibodies/*BLOOD HTLV-II Infections/BLOOD/*EPIDEMIOLOGY/*TRANSMISSION *Indians, South American Infant Male Middle Age Prevalence Sex Factors Support, U.S. Gov't, Non-P.H.S. JOURNAL ARTICLE SOURCE: National Library of Medicine. NOTICE: This material may be protected by Copyright Law (Title 17, U.S.Code).